4.7 Review

Thyrotropin, Hyperthyroidism, and Bone Mass

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 106, Issue 12, Pages E4809-E4821

Publisher

ENDOCRINE SOC
DOI: 10.1210/clinem/dgab548

Keywords

thyroxine; osteoporosis; thyrotropin; bone remodeling

Funding

  1. National Institutes of Health [R01 DK113627, U19 AG60917, R01 AG071870]

Ask authors/readers for more resources

TSH, traditionally known for regulating thyroid function, also plays a crucial role in skeletal remodeling and bone metabolism. Studies using genetically modified mouse models have shown an independent role of TSH in bone health, beyond its relationship with thyroid hormone levels.
Thyrotropin (TSH), traditionally seen as a pituitary hormone that regulates thyroid glands, has additional roles in physiology including skeletal remodeling. Population-based observations in people with euthyroidism or subclinical hyperthyroidism indicated a negative association between bone mass and low-normal TSH. The findings of correlative studies were supported by small intervention trials using recombinant human TSH (rhTSH) injection, and genetic and case-based evidence. Genetically modified mouse models, which disrupt the reciprocal relationship between TSH and thyroid hormone, have allowed us to examine an independent role of TSH. Since the first description of osteoporotic phenotype in haploinsufficient Tshr(+/-) mice with normal thyroid hormone levels, the antiosteoclastic effect of TSH has been documented in both in vitro and in vivo studies. Further studies showed that increased osteoclastogenesis in Tshr-deficient mice was mediated by tumor necrosis factor alpha. Low TSH not only increased osteoclastogenesis, but also decreased osteoblastogenesis in bone marrow-derived primary osteoblast cultures. However, later in vivo studies using small and intermittent doses of rhTSH showed a proanabolic effect, which suggests that its action might be dose and frequency dependent. TSHR was shown to interact with insulin-like growth factor 1 receptor, and vascular endothelial growth factor and Wnt pathway might play a role in TSH's effect on osteoblasts. The expression and direct skeletal effect of a biologically active splice variant of theTSH beta subunit (TSH beta v) in bone marrow-derived macrophage and other immune cells suggest a local skeletal effect of TSHR. Further studies of how locally secreted TSH beta v and systemic TSH beta interact in skeletal remodeling through the endocrine, immune, and skeletal systems will help us better understand the hyperthyroidisminduced bone disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available